• Thu, March 3, 2022

Serge Belanger Maintained (VRCA) at Strong Buy with Decreased Target to $18 on, Mar 3rd, 2022

Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $20 to $18 on, Mar 3rd, 2022.

Serge, nor any peers, have made any analyst calls on VRCA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍